Medicine

Unauthorized weight loss supplement containing banned ingredient leads to hospitalization

Laboratory tests conducted by the ministry found that the product contains the active ingredient sibutramine, a pharmaceutical substance banned in Israel and multiple other countries.

G-Slim supplement found to contain banned substance.
A problem affecting millions of patients worldwide. Chronic wounds that fail to heal.

The Israeli drug that will revolutionize treatment for diabetes patients worldwide

Ribbon-cutting ceremony at  Sheba’s Institute for Gynecological and Obstetric Ultrasound.

Turpaz CEO donates NIS 70 million to three of Israel’s leading hospitals

Medical team performing surgery

Man receives human kidney transplant after surviving 271 days with gene-edited pig organ


Israel must fight harder to keep its doctors in the country - editorial

Israel needs doctors. There are Jewish doctors around the world who may want to make Israel their home. Connecting the two is vital for a country that prides itself on solving difficult problems.

Israeli doctors perform cardiac catheterizations at Hadassah Ein Karem Hospital, in Jerusalem, on January 20, 2020.

Brain drain: Israel’s medical exodus grows as nearly 1,400 doctors leave inside three years

In 2023, 416 doctors left Israel for at least one year, compared with 530 in 2024 and a preliminary estimate of 419 in 2025.

Doctors at Shaare Zedek in Jerusalem; illustrative.

Fighting two cancers: Amir Heshmatpour’s battle against brain tumors and Iran’s regime - interview

A Persian entrepreneur with a Jewish wife, a breakthrough brain-cancer drug, and a mission against Tehran. NeOnc's Amir Heshmatpour, in his own words.

'Iran is a cancer': Iranian-born CEO takes on the regime

Targeted antibiotic gel helps 80% of pilot patients avoid foot amputation, Jerusalem trial finds

GentaGel’s biodegradable treatment releases antibiotics directly at infection sites for up to 60 days; the company is pursuing further trials and an FDA regulatory pathway.

Dr. Ariel Orbach (L), Co-Founder and CEO of GentaGel, Prof. Avi Domb (M), Inventor of GentaGel-LR Technology, and Eli Lerner (R), Co-founder and COO of GentaGel.

Medical coexistence: Arab Israeli doctors show the cost of Israel’s medical school shortage

As Israel faces a growing doctor shortage, Arab Israelis now make up 25% of physicians and play an essential role in a health system that also offers a model of coexistence.

TODAY, 25% of the country’s working physicians are Arab-Israeli.

Revolution Medicines gets FDA approval for targeted pancreatic cancer drug

Revolution said the drug is now available in the United States at $39,800 for a 30-day supply. The company added that it would make assistance available as well.

Menta "Steve" Wallace shows a bottle of daraxonrasib, Revolution Medicine?s pancreatic cancer drug, at his home in The Woodlands, Texas, U.S., May 29, 2026.

Dozens of cardiologists may have skipped internal medicine training, falsified records - report

According to a Channel 13 report, the committee was formed after a resident doctor at the center alleged that residency logs had been falsified so cardiology residents could skip the training.

View of the Kaplan Medical Center in Rehovot. January 26, 2026.

Jerusalem hospital performs first-ever alpha radiation treatment for recurring brain tumors

The technology, which emits highly bioefficient alpha particles that deliver concentrated radiation, was developed in collaboration with the Sharett Institute of Oncology and ALPHA Tau.

Doctors at Hadassah Medical Center in Jerusalem, August 2026.

Skeptical of alternative medicine, I took a leap on Chinese tonics and paid the price - opinion

I found a specialist in Tel Aviv that I’d read good things about. While not a licensed medical doctor, he tests all his tonics in the oncology department at Sheba Medical Center, Israel’s largest.

Chinese medicine: 'I dutifully brewed up his witch's concoction every night.'

SIL204 treatment may help immune system attack KRAS-driven tumors, research finds - exclusive

This comes just after SIL204 advanced into Phase 2/3 clinical evaluation at the end of July, beginning its first clinical trial at Tel Aviv Sourasky Medical Center.

Illustration of a pancreatic tumor surrounded by immune cells